![Frontiers | Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies Frontiers | Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies](https://www.frontiersin.org/files/Articles/613114/fimmu-11-613114-HTML/image_m/fimmu-11-613114-g001.jpg)
Frontiers | Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
![Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics - ScienceDirect Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2329050121001091-fx1.jpg)
Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics - ScienceDirect
![Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated Mechanism - ScienceDirect Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated Mechanism - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124713007560-fx1.jpg)
Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated Mechanism - ScienceDirect
Association between the CXCL12 → CXCR4 axis and vascular endothelial... | Download Scientific Diagram
![Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity | Experimental & Molecular Medicine Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity | Experimental & Molecular Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs12276-020-00500-y/MediaObjects/12276_2020_500_Fig1_HTML.png)
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity | Experimental & Molecular Medicine
![Alteration of the HIF-1α/VEGF Signaling Pathway and Disruption of the Cell Cycle by Second Generation Carbosilan Dendrimers | Biomacromolecules Alteration of the HIF-1α/VEGF Signaling Pathway and Disruption of the Cell Cycle by Second Generation Carbosilan Dendrimers | Biomacromolecules](https://pubs.acs.org/cms/10.1021/acs.biomac.2c00899/asset/images/large/bm2c00899_0010.jpeg)
Alteration of the HIF-1α/VEGF Signaling Pathway and Disruption of the Cell Cycle by Second Generation Carbosilan Dendrimers | Biomacromolecules
![Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development - Lee - 2001 - Developmental Dynamics - Wiley Online Library Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development - Lee - 2001 - Developmental Dynamics - Wiley Online Library](https://anatomypubs.onlinelibrary.wiley.com/cms/asset/4e8e336e-44b5-482a-8825-87319b5d5771/mfig005.jpg)
Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development - Lee - 2001 - Developmental Dynamics - Wiley Online Library
Hypoxia-Induced Reactive Oxygen Species Cause Chromosomal Abnormalities in Endothelial Cells in the Tumor Microenvironment | PLOS ONE
![Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition | Journal of Pharmacology and Experimental Therapeutics Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/sites/default/files/highwire/jpet/384/3.cover-source.jpg)
Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition | Journal of Pharmacology and Experimental Therapeutics
![Overexpression of VEGF in dermal fibroblast cells accelerates the angiogenesis and wound healing function: in vitro and in vivo studies | Scientific Reports Overexpression of VEGF in dermal fibroblast cells accelerates the angiogenesis and wound healing function: in vitro and in vivo studies | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-23304-8/MediaObjects/41598_2022_23304_Fig1_HTML.png)
Overexpression of VEGF in dermal fibroblast cells accelerates the angiogenesis and wound healing function: in vitro and in vivo studies | Scientific Reports
![IJMS | Free Full-Text | Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies IJMS | Free Full-Text | Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies](https://pub.mdpi-res.com/ijms/ijms-22-00520/article_deploy/html/images/ijms-22-00520-g001.png?1609998430)
IJMS | Free Full-Text | Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies
![IJMS | Free Full-Text | Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes IJMS | Free Full-Text | Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes](https://pub.mdpi-res.com/ijms/ijms-20-06140/article_deploy/html/images/ijms-20-06140-g001.png?1577772802)